NAT CAT Coverage for Renewable Energy

Mitigating risk where the skies get rough

As the frequency and severity of natural catastrophes (NAT CAT) continue to rise globally, renewable energy projects face growing exposure to perils ranging from severe convective storms and wildfire to flood and earthquake. These events can cause significant physical damage to renewable energy assets and associated transmission infrastructure, as well as prolonged project downtime.

Amwins Global Risks, through its specialist Energy, Power and Infrastructure practice, can provide additional protection where traditional coverage may fall short.

Our dedicated Excess of Loss (XOL) facility provides additional catastrophe capacity above primary property and construction insurance programs, helping renewable energy investors and developers bridge the gap between available market limits and total project exposure.

Coverage is available worldwide for operational and construction-phase renewable energy projects exposed to severe convective storm and other named natural catastrophe perils.

Why natural catastrophe insurance matters for renewable energy

Renewable energy projects can be particularly exposed to natural catastrophes. When significant damage occurs, repair and replacement lead times can extend the financial impact well beyond the initial physical loss.

Our renewable energy natural catastrophe insurance facility includes Business Interruption (BI) and Delay in Start-Up (DSU) coverage, helping insureds manage the longer-term financial consequences of a major NAT CAT event.

Program highlights

Excess of loss coverage. Tailored protection for named NAT CAT perils, including hail and wind
Robust financial protection. Includes both business interruption and delay in start-up
Scalable to your risk profile. Up to $50M of CAT limit available per placement
Project flexibility. Designed for both single-site and portfolio solar projects
Worldwide availability. Coverage available for renewable energy project around the globe
Trusted security. Backed by AM Best “A”-rated, non-admitted London and Lloyd’s markets